Table:
begin	end	state
1	26	cytoplasmic
27	47	transmembrane
48	52	non-cytoplasmic
53	70	transmembrane
71	105	cytoplasmic
106	128	transmembrane
129	134	non-cytoplasmic
135	153	transmembrane
154	161	cytoplasmic
162	183	transmembrane
184	204	non-cytoplasmic
205	227	transmembrane
228	247	cytoplasmic
248	270	transmembrane
271	289	non-cytoplasmic
290	308	transmembrane
309	338	cytoplasmic
339	361	transmembrane
362	366	non-cytoplasmic
367	387	transmembrane
388	406	cytoplasmic
407	427	transmembrane
428	432	non-cytoplasmic
433	452	transmembrane
453	458	cytoplasmic

Input:
>BWI76_RS07360
MKDASTSSETIEESGPTLHRGLQNRHIQLIALGGAIGTGLFLGIGPAIQMAGPAVLLGYA
VAGIVAFLIMRQLGEMVVEEPVSGSFAHFAYKYWGPFAGFLSGWNYWVMFVLVGMAELTA
AGIYMQYWLPDVPTWIWAAAFFLIINAVNLVNVRLYGEAEFWFALIKVLAIIGMIGFGLW
MLFGGHGGSKAGIDNLWKHGGFFATGWHGLIMSLAVIMFSFGGLELIGITAAEAQNPEKS
IPKAVNQVVYRILLFYIGSLVVLLALYPWVEIQSDSSPFVMIFHNLDSNVVASALNFVIL
VASLSVYNSGVYSNSRMLFGLSVQGNAPKFLARVSKRGVPVNSLLLSGIITSLVVVLNYL
LPQKALGLLMALVVATLLLNWIMICLAHLKFRAAQRRKGREPKFKALLSPASNYICIAFL
ALILVLMCTIDGMRLSAILLPVWILFLFAAFKTLRRTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server